Protalix
Market Access/ News/ News/ Top stories
Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021
Phil Taylor
Chiesi, Fabry disease, Protalix, rare disease
0 Comment
X
Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021
https://pharmaphorum.com/news/chiesis-flagship-fabry-drug-heads-for-fda-verdict-in-early-2021/
Chiesi starts rare diseases division, ahead of potential Fabry disease filing
Richard Staines
Chiesi, Fabry disease, Protalix, R&D, Rare diseases, respiratory, Takeda
0 Comment
X
Chiesi starts rare diseases division, ahead of potential Fabry disease filing
https://pharmaphorum.com/news/chiesi-starts-rare-diseases-division-as-fabry-treatment/